SE412235B - Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer - Google Patents

Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer

Info

Publication number
SE412235B
SE412235B SE7308709A SE7308709A SE412235B SE 412235 B SE412235 B SE 412235B SE 7308709 A SE7308709 A SE 7308709A SE 7308709 A SE7308709 A SE 7308709A SE 412235 B SE412235 B SE 412235B
Authority
SE
Sweden
Prior art keywords
tienylmethyl
tetrahydronoripavines
tebains
hydroxial
endoeteno
Prior art date
Application number
SE7308709A
Other languages
English (en)
Inventor
A Langbein
H Merz
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE412235B publication Critical patent/SE412235B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7308709A 1972-06-21 1973-06-20 Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer SE412235B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2230154A DE2230154A1 (de) 1972-06-21 1972-06-21 N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
SE412235B true SE412235B (sv) 1980-02-25

Family

ID=5848276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7308709A SE412235B (sv) 1972-06-21 1973-06-20 Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer

Country Status (14)

Country Link
US (1) US3931189A (sv)
JP (1) JPS5614673B2 (sv)
AT (7) AT328098B (sv)
BE (1) BE801271A (sv)
CH (7) CH594672A5 (sv)
DE (1) DE2230154A1 (sv)
DK (1) DK141629C (sv)
ES (3) ES416106A1 (sv)
FI (1) FI57261C (sv)
FR (1) FR2189066B1 (sv)
GB (1) GB1431385A (sv)
NL (1) NL7308555A (sv)
NO (1) NO139050C (sv)
SE (1) SE412235B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232026A (en) * 1978-07-20 1980-11-04 Merck & Co., Inc. Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them
JPS60119848A (ja) * 1983-11-30 1985-06-27 三井建設株式会社 繊維補強コンクリ−ト並びにその施工法
JPS62298530A (ja) * 1986-06-16 1987-12-25 Otsuka Pharmaceut Co Ltd 坐薬用医薬組成物
CN1233645C (zh) * 2001-09-14 2005-12-28 中国人民解放军军事医学科学院毒物药物研究所 新的东罂粟碱衍生物及其医药用途
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
CA2731939C (en) 2008-07-30 2017-05-23 Purdue Pharma L.P. Buprenorphine analogs
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
GB1136764A (en) * 1965-08-13 1968-12-18 Reckitt & Sons Ltd Derivatives of thebaine and oripavine
GB1146272A (en) * 1966-01-17 1969-03-26 Reckitt & Sons Ltd Novel thebaine and oripavine derivatives
GB1223445A (en) * 1968-07-18 1971-02-24 Reckitt & Colmann Prod Ltd Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
DE2107989A1 (de) * 1971-02-19 1972-09-07 Boehringer Sohn Ingelheim N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
JPS5614673B2 (sv) 1981-04-06
FR2189066A1 (sv) 1974-01-25
ES425015A1 (es) 1976-07-01
ATA461974A (de) 1975-05-15
ES416106A1 (es) 1976-02-16
AT328100B (de) 1976-03-10
AT328099B (de) 1976-03-10
ATA462374A (de) 1975-07-15
NO139050B (no) 1978-09-18
ATA462274A (de) 1975-04-15
ATA462074A (de) 1975-05-15
FI57261C (fi) 1980-07-10
DE2230154A1 (de) 1974-01-17
DK141629C (da) 1980-09-29
AT328098B (de) 1976-03-10
NL7308555A (sv) 1973-12-27
NO139050C (no) 1979-01-03
CH587264A5 (sv) 1977-04-29
AT329198B (de) 1976-04-26
CH585752A5 (sv) 1977-03-15
CH585751A5 (sv) 1977-03-15
GB1431385A (en) 1976-04-07
CH594673A5 (sv) 1978-01-13
CH586224A5 (sv) 1977-03-31
FI57261B (fi) 1980-03-31
CH585753A5 (sv) 1977-03-15
ATA461874A (de) 1975-05-15
FR2189066B1 (sv) 1976-12-31
AT327409B (de) 1976-01-26
AU5721173A (en) 1975-01-09
ES425010A1 (es) 1976-06-16
AT328101B (de) 1976-03-10
ATA462174A (de) 1975-05-15
US3931189A (en) 1976-01-06
DK141629B (da) 1980-05-12
JPS4954390A (sv) 1974-05-27
AT325219B (de) 1975-10-10
BE801271A (fr) 1973-12-21
CH594672A5 (sv) 1978-01-13

Similar Documents

Publication Publication Date Title
NO783636L (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
BE783440A (fr) Derives de benzofuranne et leur preparation
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
AR196219A1 (es) Derivados de triazolilorgano-fosforo, y procedimiento para su preparacion
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE412235B (sv) Analogiforfarande for framstellning av n-(furyl-och tienylmetyl)-6,14-endoeteno-7 alfa-hydroxialkyltetrahydronororipaviner- och -tebainer
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
FI55033C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva pyrazin-4-oxidderivat
SE410603B (sv) Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE409035B (sv) Analogiforfarande for framstellning av n-(faryl-och tienylmetyl)-7alfa-6,14-endoeteno-tetrahydronororipaviner och tebainer
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE413510B (sv) Analogiforfarande for framstellning av n-(furyl- och tienylmetyl)-desoxi-normorfiner och norkodeiner
NO137725C (no) Fremgangsmaate for selektiv fremstilling av 1,2-dikloretan
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat